SlideShare une entreprise Scribd logo
1  sur  17
DIABETES AND
STROKE
DR SUDHIR KUMAR MD (MED) DM
(NEURO)
CONSULTANT NEUROLOGIST
APOLLO HOSPITALS, HYDERABAD
My Talk Would Cover:
 Diabetes as a risk factor for stroke,
 Sugar control in patients with acute stroke,
 Sugar control in post-stroke patients,
Diabetes: Risk factor for stroke
 Type 2 DM is associated with 2- to 3-fold increase in
the risk of stroke.
 About 10% of newly diagnosed T2DM patients
develop stroke within the first 5 years of diagnosis,
 The absolute risk of stroke is higher in older people
(1% in 30-44 years versus 20% for >75 years old),
 However, the relative risk of stroke (as compared to
general population) is higher in younger people (5.6
times)
(Stroke,2007)
Factors in T2DM Predicting an
Increased Stroke Risk (1)
 Proteinuria (OR: 3.23)
 High systolic BP (OR:3.1)
 High diastolic BP (OR: 3.3)
 FBS > 200 mg% (OR: 1.8)
 HbA1C> 9.5% (OR: 1.7)
(Stroke, 1999)
Factors in T2DM Predicting an
Increased Stroke Risk (2)
 Hyperuricemia: Hazard ratio of 1.9 above mean uric
acid >5 mg% (Stroke, 1998)
 Age>60 (Hazard ratio 4.8 versus those <50)
(Arch Int Med, 1999)
Diabetes as a Risk Factor for
Stroke in Women
 Systematic review and meta-analysis of 64 cohort
studies between 1966 to 2013,
 Pooled maximum-adjusted RR was 2.3 in women and
1.8 in men,
 Compared with men with Type 2 DM, women with
Type 2 DM had a 27% greater risk of stroke. (Lancet,
2014)
 Compared with men with Type 1 DM, women with
Type 1 DM had a 37% greater risk of stroke. (Lancet
Diabetes Endocrinol, 2015)
Prediabetes and Risk of Stroke
 Prediabetes defined as FBS 100-125 m% did not
show an increase in risk of stroke,
 Prediabetes defined as FBS 110-125 m% showed a
modest increase in risk of stroke (RR 1.21, p=0.03),
 Impaired glucose tolerance resulted in modest
increase in the risk of stroke (RR 1.26, P<0.001),
(BMJ, 2012)
Hyperglycemia and Acute
Stroke (1)
 Among patients admitted with stroke, 40-50% have
diabetes mellitus (Stroke, 2009)
 Additional 20% have hyperglycemia without any
history of diabetes, termed as stress hyperglycemia,
 So, a total 0f 60-70% of patients with acute stroke
have hyperglycemia at admission.
 Admission plasma glucose>110 mg% and HbA1C>
6.2% are good predictors of (undiagnosed) diabetes
mellitus in patients with acute stroke, (Age Ageing,
2004)
Hyperglycemia and Acute
Stroke (2)
 Patients with hyperglycemia and acute stroke have
prolonged hospital stay and incur higher
hospitalization costs (Neurology 2002)
 Hyperglycemia at admission in patients with stroke
results in poor functional outcome at 3 months
(Neurology,1999)
 Hyperglycemia independently increases the risk of
death at 90 days, 1 year and 6 years after stroke (all
p<0.01) (Neurology 2002)
Hyperglycemia and Acute
Stroke (3)
 Hyperglycemia leads to: a) Lesser salvage of
mismatch tissue from infarction and b) Increase in
infarct size/volume over time, thus resulting in poorer
outcomes, as based on MRI diffusion-perfusion
studies
 Acute hyperglycemia increases brain lactate
production and facilitates conversion of hypoperfused
at-risk tissue into infarction.
(Ann Neurology 2002)
Sugar Control in Acute Stroke
Setting
 Strict sugar control would lower the sugars, thereby,
improving functional outcomes; however, it may also
result in hypoglycemia, resulting in brain damage.
 GIST-UK trial: Patients with blood sugar between 108-
306 mg% were treated with G-K-I infusions to
maintain capillary glucose between 70-125 mg%.
 No difference in mortality or severe disability was
seen at 90 days after stroke, as compared to placebo
group.
(Lancet Neurol 2007)
Tight Sugar Control Leads to
More Hypoglycemia
 Glucose regulation in acute stroke patients (GRASP)
trial (Stroke, 2009)
 3 arms- tight control (70-110 mg%), loose control (70-
200mg%) and control usual care (70-300mg%)
 Insulin infusion was used to achieve the targets,
 The overall rates of hypoglycemia (<55 mg%) were
5% in loose and control usual care groups, whereas it
was 30% in the tight group.
Intensive Insulin Therapy leads to
Larger Infarct growth
 INSULINFARCT study (Stroke, 2012)
 180 patients with MRI proven ischemic stroke (NIHSS
score 5-25) were enrolled.
 Received intensive insulin therapy (IIT) or usual
subcutaneous insulin for 24 hours
 95% within IIT group and 67% in subcutaneous insulin
group had sugar within 126 mg%
 Infract growth was lower in subcutaneous insulin group
 Functional outcome and death rates were similar at 90
days.
American Stroke Association
Guideline
 Maintain plasma glucose levels within 140 to 180
mg% in the first 24 hours,
 Close monitoring should be done to detect
hypoglycemia,
 For patients being considered for IV thrombolysis,
blood sugar should be within 50-500 mg% range.
(Stroke,2013)
Sugar Control in Post-stroke
Period
 Sugar control is important in patients with stroke to
prevent recurrence of stroke,
 Diabetes mellitus and age are two most important
predictors for stroke recurrence,
 About 9% of recurrent strokes are attributable to
diabetes mellitus,
 Diabetes is also linked to the presence of multiple
infarcts on brain scan.
 Goal for HbA1C level is less than 7%.
(Stroke, 2006)
CONCLUSIONS
 Diabetes and prediabetes are important risk factors for
stroke,
 Majority of patients with acute stroke have
hyperglycemia,
 Hyperglycemia worsens the outcome in stroke patients,
 IIT is not useful in acute stroke setting,
 Moderate sugar control is advisable in acute stroke
setting,
 HbA1C should be less than 7% in post-stroke patients.
THANKS
drsudhirkumar@yahoo.com
9866193953
http://bestneurodoctor.blogspot.in
https://www.facebook.com/bestneurologist

Contenu connexe

Tendances

Management of hypertension in diabetes
Management of hypertension in diabetesManagement of hypertension in diabetes
Management of hypertension in diabetes
mondy19
 

Tendances (20)

DIABETES AND CARDIOVASCULAR DISEASE - THE CONTINUUM
DIABETES AND CARDIOVASCULAR DISEASE - THE CONTINUUMDIABETES AND CARDIOVASCULAR DISEASE - THE CONTINUUM
DIABETES AND CARDIOVASCULAR DISEASE - THE CONTINUUM
 
Management of hypertension in elderly person.
Management of hypertension in elderly person.Management of hypertension in elderly person.
Management of hypertension in elderly person.
 
SGLT2 inhibitors in Diabetic Kidney Disease
SGLT2 inhibitors in Diabetic Kidney DiseaseSGLT2 inhibitors in Diabetic Kidney Disease
SGLT2 inhibitors in Diabetic Kidney Disease
 
Ideal basal insulin: Degludeg
Ideal basal insulin: DegludegIdeal basal insulin: Degludeg
Ideal basal insulin: Degludeg
 
Inpatient Diabetes Management - How to Control Hyperglycemia inhsopital
Inpatient Diabetes Management - How to Control Hyperglycemia inhsopitalInpatient Diabetes Management - How to Control Hyperglycemia inhsopital
Inpatient Diabetes Management - How to Control Hyperglycemia inhsopital
 
Management of hypertension in diabetes
Management of hypertension in diabetesManagement of hypertension in diabetes
Management of hypertension in diabetes
 
Advance Results
Advance ResultsAdvance Results
Advance Results
 
Insulin therapy in type 2 diabetes
Insulin therapy in type 2 diabetesInsulin therapy in type 2 diabetes
Insulin therapy in type 2 diabetes
 
Hypertension & Diabetes
Hypertension & DiabetesHypertension & Diabetes
Hypertension & Diabetes
 
Management of Diabetic Nephropathy
Management of Diabetic NephropathyManagement of Diabetic Nephropathy
Management of Diabetic Nephropathy
 
Diabetes care in hospital
Diabetes care in hospitalDiabetes care in hospital
Diabetes care in hospital
 
ADA 2022.pptx
ADA 2022.pptxADA 2022.pptx
ADA 2022.pptx
 
Critical care ppt
Critical care pptCritical care ppt
Critical care ppt
 
Updates of Diabetes Management by Dr Selim
Updates of Diabetes Management by Dr SelimUpdates of Diabetes Management by Dr Selim
Updates of Diabetes Management by Dr Selim
 
Insulin Therapy for Type 2 Diabetes:Update
Insulin Therapy for Type 2 Diabetes:Update Insulin Therapy for Type 2 Diabetes:Update
Insulin Therapy for Type 2 Diabetes:Update
 
Sglt2i Empagliflogin canagliflogin dapagliflogin- beyond glycemic control
Sglt2i Empagliflogin canagliflogin dapagliflogin- beyond glycemic controlSglt2i Empagliflogin canagliflogin dapagliflogin- beyond glycemic control
Sglt2i Empagliflogin canagliflogin dapagliflogin- beyond glycemic control
 
Ueda2016 woman’s health &amp; diabetes - lobna el toony
Ueda2016 woman’s health &amp; diabetes - lobna el toonyUeda2016 woman’s health &amp; diabetes - lobna el toony
Ueda2016 woman’s health &amp; diabetes - lobna el toony
 
ADA GUIDELINE.pptx
ADA GUIDELINE.pptxADA GUIDELINE.pptx
ADA GUIDELINE.pptx
 
Diabetes and elderly
Diabetes and elderlyDiabetes and elderly
Diabetes and elderly
 
Inpatient hyperglycemia.ver3 (3)
Inpatient hyperglycemia.ver3 (3)Inpatient hyperglycemia.ver3 (3)
Inpatient hyperglycemia.ver3 (3)
 

En vedette

Stroke and dietary risk factors
Stroke and dietary risk factorsStroke and dietary risk factors
Stroke and dietary risk factors
sammi2823
 
An Evaluation of A Stroke Rehabilitation Study At Rotman Research Institute
An Evaluation of A Stroke  Rehabilitation Study At Rotman  Research InstituteAn Evaluation of A Stroke  Rehabilitation Study At Rotman  Research Institute
An Evaluation of A Stroke Rehabilitation Study At Rotman Research Institute
Joanna (Yijing) Rong
 
Acute stroke early recognition and management
Acute stroke early recognition and managementAcute stroke early recognition and management
Acute stroke early recognition and management
webzforu
 

En vedette (20)

Ischemic stroke
Ischemic strokeIschemic stroke
Ischemic stroke
 
Type 2 Diabetes and Dementia: What's the link? A Review of the Metabolic and ...
Type 2 Diabetes and Dementia: What's the link? A Review of the Metabolic and ...Type 2 Diabetes and Dementia: What's the link? A Review of the Metabolic and ...
Type 2 Diabetes and Dementia: What's the link? A Review of the Metabolic and ...
 
Stroke and dietary risk factors
Stroke and dietary risk factorsStroke and dietary risk factors
Stroke and dietary risk factors
 
Let's Talk Research 2015 - Jo Gibson oral presentation - Medication adherenc...
Let's Talk Research 2015  - Jo Gibson oral presentation - Medication adherenc...Let's Talk Research 2015  - Jo Gibson oral presentation - Medication adherenc...
Let's Talk Research 2015 - Jo Gibson oral presentation - Medication adherenc...
 
Dehydration: A Risk Factor for Serious Stroke Effects
Dehydration: A Risk Factor for Serious Stroke EffectsDehydration: A Risk Factor for Serious Stroke Effects
Dehydration: A Risk Factor for Serious Stroke Effects
 
An Evaluation of A Stroke Rehabilitation Study At Rotman Research Institute
An Evaluation of A Stroke  Rehabilitation Study At Rotman  Research InstituteAn Evaluation of A Stroke  Rehabilitation Study At Rotman  Research Institute
An Evaluation of A Stroke Rehabilitation Study At Rotman Research Institute
 
Dietary risk factors and stroke
Dietary risk factors and strokeDietary risk factors and stroke
Dietary risk factors and stroke
 
Blood Clot In Brain Treatment In Chennai | Neurologist In India
Blood Clot In Brain Treatment In Chennai | Neurologist In IndiaBlood Clot In Brain Treatment In Chennai | Neurologist In India
Blood Clot In Brain Treatment In Chennai | Neurologist In India
 
Acute stroke early recognition and management
Acute stroke early recognition and managementAcute stroke early recognition and management
Acute stroke early recognition and management
 
Risk factor for stroke
Risk factor for strokeRisk factor for stroke
Risk factor for stroke
 
Homocysteine as a risk factor in stroke
Homocysteine as a risk factor in strokeHomocysteine as a risk factor in stroke
Homocysteine as a risk factor in stroke
 
CARDIOVASCULAR DISEASE AND DIABETES
CARDIOVASCULAR DISEASE AND DIABETESCARDIOVASCULAR DISEASE AND DIABETES
CARDIOVASCULAR DISEASE AND DIABETES
 
Stroke
StrokeStroke
Stroke
 
STROKE LECTURE By Arlyn M. Valencia, M.D. Associate Professo University Of Ne...
STROKE LECTURE By Arlyn M. Valencia, M.D. Associate Professo University Of Ne...STROKE LECTURE By Arlyn M. Valencia, M.D. Associate Professo University Of Ne...
STROKE LECTURE By Arlyn M. Valencia, M.D. Associate Professo University Of Ne...
 
Cerebrovascular disease (CVA / Stroke)
Cerebrovascular disease (CVA / Stroke)Cerebrovascular disease (CVA / Stroke)
Cerebrovascular disease (CVA / Stroke)
 
Stroke Presentation Ms
Stroke Presentation MsStroke Presentation Ms
Stroke Presentation Ms
 
Ppt.stroke
Ppt.strokePpt.stroke
Ppt.stroke
 
Ischemic stroke
Ischemic strokeIschemic stroke
Ischemic stroke
 
Stroke presentation
Stroke presentationStroke presentation
Stroke presentation
 
Stroke (1)
Stroke (1)Stroke (1)
Stroke (1)
 

Similaire à Diabetes and stroke

26.09 metformain as a antiaterosceoti
26.09 metformain as a antiaterosceoti26.09 metformain as a antiaterosceoti
26.09 metformain as a antiaterosceoti
Rajeev Agarwala
 
Microalbuminuria in Saudi Adults with Type 1 Diabetes Mellitus_Crimson Publis...
Microalbuminuria in Saudi Adults with Type 1 Diabetes Mellitus_Crimson Publis...Microalbuminuria in Saudi Adults with Type 1 Diabetes Mellitus_Crimson Publis...
Microalbuminuria in Saudi Adults with Type 1 Diabetes Mellitus_Crimson Publis...
CrimsonPublishersIOD
 
Blood pressure control in diabetes
Blood pressure control in diabetesBlood pressure control in diabetes
Blood pressure control in diabetes
BALASUBRAMANIAM IYER
 
Systemic hypertension and scope of homoeopathy
Systemic hypertension and scope of homoeopathySystemic hypertension and scope of homoeopathy
Systemic hypertension and scope of homoeopathy
smita brahmachari
 
Galvus kol slide deck 2011 pcc approved
Galvus kol slide deck 2011 pcc approvedGalvus kol slide deck 2011 pcc approved
Galvus kol slide deck 2011 pcc approved
Dr. Lin
 
Hb a1c goals
Hb a1c goalsHb a1c goals
Hb a1c goals
Daniel Wu
 
Perioperative management of diabetes
Perioperative management of diabetesPerioperative management of diabetes
Perioperative management of diabetes
mzjabor
 

Similaire à Diabetes and stroke (20)

Addressing hypertension to reduce the burden of stroke 19 feb2018 (1)
Addressing hypertension to reduce  the burden of stroke 19 feb2018 (1)Addressing hypertension to reduce  the burden of stroke 19 feb2018 (1)
Addressing hypertension to reduce the burden of stroke 19 feb2018 (1)
 
26.09 metformain as a antiaterosceoti
26.09 metformain as a antiaterosceoti26.09 metformain as a antiaterosceoti
26.09 metformain as a antiaterosceoti
 
Blood sugar
Blood sugarBlood sugar
Blood sugar
 
Microalbuminuria in Saudi Adults with Type 1 Diabetes Mellitus_Crimson Publis...
Microalbuminuria in Saudi Adults with Type 1 Diabetes Mellitus_Crimson Publis...Microalbuminuria in Saudi Adults with Type 1 Diabetes Mellitus_Crimson Publis...
Microalbuminuria in Saudi Adults with Type 1 Diabetes Mellitus_Crimson Publis...
 
Blood pressure control in diabetes
Blood pressure control in diabetesBlood pressure control in diabetes
Blood pressure control in diabetes
 
DM Lessons and Guidance
DM Lessons and GuidanceDM Lessons and Guidance
DM Lessons and Guidance
 
Systemic hypertension and scope of homoeopathy
Systemic hypertension and scope of homoeopathySystemic hypertension and scope of homoeopathy
Systemic hypertension and scope of homoeopathy
 
Crimson Publishers: Insulin Therapy and Cardiovascular Outcome Trials (CVOTs)...
Crimson Publishers: Insulin Therapy and Cardiovascular Outcome Trials (CVOTs)...Crimson Publishers: Insulin Therapy and Cardiovascular Outcome Trials (CVOTs)...
Crimson Publishers: Insulin Therapy and Cardiovascular Outcome Trials (CVOTs)...
 
Umpierrez%20 inpatient non_icu%20guidelines_7_2010[1][1]
Umpierrez%20 inpatient non_icu%20guidelines_7_2010[1][1]Umpierrez%20 inpatient non_icu%20guidelines_7_2010[1][1]
Umpierrez%20 inpatient non_icu%20guidelines_7_2010[1][1]
 
BP Targets-where are we now.pptx
BP Targets-where are we now.pptxBP Targets-where are we now.pptx
BP Targets-where are we now.pptx
 
Diabetes mellitus and hypertension
Diabetes mellitus and hypertensionDiabetes mellitus and hypertension
Diabetes mellitus and hypertension
 
Galvus kol slide deck 2011 pcc approved
Galvus kol slide deck 2011 pcc approvedGalvus kol slide deck 2011 pcc approved
Galvus kol slide deck 2011 pcc approved
 
Type 2 DM and CKD
Type 2 DM and CKDType 2 DM and CKD
Type 2 DM and CKD
 
Hb a1c goals
Hb a1c goalsHb a1c goals
Hb a1c goals
 
Semaglutide journal club
Semaglutide journal clubSemaglutide journal club
Semaglutide journal club
 
ueda2012 metabolic memory-d.mgahed
ueda2012 metabolic memory-d.mgahedueda2012 metabolic memory-d.mgahed
ueda2012 metabolic memory-d.mgahed
 
Dm medications cv safety
Dm medications cv safetyDm medications cv safety
Dm medications cv safety
 
Diagnosis & Management of Resistant Hypertension
Diagnosis & Management of Resistant HypertensionDiagnosis & Management of Resistant Hypertension
Diagnosis & Management of Resistant Hypertension
 
Abbotsford feb 26 2014
Abbotsford feb 26 2014Abbotsford feb 26 2014
Abbotsford feb 26 2014
 
Perioperative management of diabetes
Perioperative management of diabetesPerioperative management of diabetes
Perioperative management of diabetes
 

Plus de Sudhir Kumar

Plus de Sudhir Kumar (20)

Neurological Evaluation of Acute Ischemic stroke in Emergency Room
Neurological Evaluation of Acute Ischemic stroke in Emergency RoomNeurological Evaluation of Acute Ischemic stroke in Emergency Room
Neurological Evaluation of Acute Ischemic stroke in Emergency Room
 
Lifestyle Measures to Prevent Brain Diseases.pptx
Lifestyle Measures to Prevent Brain Diseases.pptxLifestyle Measures to Prevent Brain Diseases.pptx
Lifestyle Measures to Prevent Brain Diseases.pptx
 
MIGRAINE
MIGRAINEMIGRAINE
MIGRAINE
 
COVID-19 Presenting as stroke- mechanisms, diagnosis and treatment
COVID-19 Presenting as stroke- mechanisms, diagnosis and treatmentCOVID-19 Presenting as stroke- mechanisms, diagnosis and treatment
COVID-19 Presenting as stroke- mechanisms, diagnosis and treatment
 
CHRONIC PAIN AND DEPRESSION: Cause or Effect or Linked?
CHRONIC PAIN AND DEPRESSION: Cause or Effect or Linked?CHRONIC PAIN AND DEPRESSION: Cause or Effect or Linked?
CHRONIC PAIN AND DEPRESSION: Cause or Effect or Linked?
 
Neurological Manifestations of COVID-19 Infection
Neurological Manifestations of COVID-19 InfectionNeurological Manifestations of COVID-19 Infection
Neurological Manifestations of COVID-19 Infection
 
ZONISAMIDE IN TREATMENT OF EPILEPSY
ZONISAMIDE IN TREATMENT OF EPILEPSYZONISAMIDE IN TREATMENT OF EPILEPSY
ZONISAMIDE IN TREATMENT OF EPILEPSY
 
Multiple sclerosis: fighting the invisible
Multiple sclerosis: fighting the  invisibleMultiple sclerosis: fighting the  invisible
Multiple sclerosis: fighting the invisible
 
Managing stroke beyond windlow period
Managing stroke beyond windlow periodManaging stroke beyond windlow period
Managing stroke beyond windlow period
 
WHEN STROKE STRIKES PREGNANCY
WHEN STROKE STRIKES PREGNANCYWHEN STROKE STRIKES PREGNANCY
WHEN STROKE STRIKES PREGNANCY
 
MANAGEMENT OF ACUTE STROKE
MANAGEMENT OF ACUTE STROKEMANAGEMENT OF ACUTE STROKE
MANAGEMENT OF ACUTE STROKE
 
NEDA in multiple sclerosis
NEDA in multiple sclerosisNEDA in multiple sclerosis
NEDA in multiple sclerosis
 
NEUROLOGICAL DISORDERS DUE TO METABOLIC DERANGEMENTS
NEUROLOGICAL DISORDERS DUE TO METABOLIC DERANGEMENTSNEUROLOGICAL DISORDERS DUE TO METABOLIC DERANGEMENTS
NEUROLOGICAL DISORDERS DUE TO METABOLIC DERANGEMENTS
 
Management of High Disease Activity in Multiple Sclerosis (MS)
Management of High Disease Activity in Multiple Sclerosis (MS)Management of High Disease Activity in Multiple Sclerosis (MS)
Management of High Disease Activity in Multiple Sclerosis (MS)
 
Multiple sclerosis: Revised diagnostic criteria
Multiple sclerosis: Revised diagnostic criteria Multiple sclerosis: Revised diagnostic criteria
Multiple sclerosis: Revised diagnostic criteria
 
Marketing one's Products and Skills
Marketing one's Products and SkillsMarketing one's Products and Skills
Marketing one's Products and Skills
 
Role of Blood Pressure in Recurrent Stroke
Role of Blood Pressure in Recurrent StrokeRole of Blood Pressure in Recurrent Stroke
Role of Blood Pressure in Recurrent Stroke
 
Palmitoylethanolamide in the Treatment of Neuropathic Pain
Palmitoylethanolamide in the Treatment of Neuropathic Pain Palmitoylethanolamide in the Treatment of Neuropathic Pain
Palmitoylethanolamide in the Treatment of Neuropathic Pain
 
Newer drugs for the treatment of motor symptoms of Parkinson's Disease
Newer drugs for the treatment of motor symptoms of Parkinson's DiseaseNewer drugs for the treatment of motor symptoms of Parkinson's Disease
Newer drugs for the treatment of motor symptoms of Parkinson's Disease
 
Management of acute stroke
Management of acute strokeManagement of acute stroke
Management of acute stroke
 

Dernier

Pune Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Pune No💰Adva...
Pune Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Pune No💰Adva...Pune Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Pune No💰Adva...
Pune Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Pune No💰Adva...
Sheetaleventcompany
 
Electrocardiogram (ECG) physiological basis .pdf
Electrocardiogram (ECG) physiological basis .pdfElectrocardiogram (ECG) physiological basis .pdf
Electrocardiogram (ECG) physiological basis .pdf
MedicoseAcademics
 
Jual Obat Aborsi Di Dubai UAE Wa 0838-4800-7379 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi Di Dubai UAE Wa 0838-4800-7379 Obat Penggugur Kandungan CytotecJual Obat Aborsi Di Dubai UAE Wa 0838-4800-7379 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi Di Dubai UAE Wa 0838-4800-7379 Obat Penggugur Kandungan Cytotec
jualobat34
 
👉 Chennai Sexy Aunty’s WhatsApp Number 👉📞 7427069034 👉📞 Just📲 Call Ruhi Colle...
👉 Chennai Sexy Aunty’s WhatsApp Number 👉📞 7427069034 👉📞 Just📲 Call Ruhi Colle...👉 Chennai Sexy Aunty’s WhatsApp Number 👉📞 7427069034 👉📞 Just📲 Call Ruhi Colle...
👉 Chennai Sexy Aunty’s WhatsApp Number 👉📞 7427069034 👉📞 Just📲 Call Ruhi Colle...
rajnisinghkjn
 
Dehradun Call Girl Service ❤️🍑 8854095900 👄🫦Independent Escort Service Dehradun
Dehradun Call Girl Service ❤️🍑 8854095900 👄🫦Independent Escort Service DehradunDehradun Call Girl Service ❤️🍑 8854095900 👄🫦Independent Escort Service Dehradun
Dehradun Call Girl Service ❤️🍑 8854095900 👄🫦Independent Escort Service Dehradun
Sheetaleventcompany
 
Nagpur Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Nagpur No💰...
Nagpur Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Nagpur No💰...Nagpur Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Nagpur No💰...
Nagpur Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Nagpur No💰...
Sheetaleventcompany
 
❤️Amritsar Escorts Service☎️9815674956☎️ Call Girl service in Amritsar☎️ Amri...
❤️Amritsar Escorts Service☎️9815674956☎️ Call Girl service in Amritsar☎️ Amri...❤️Amritsar Escorts Service☎️9815674956☎️ Call Girl service in Amritsar☎️ Amri...
❤️Amritsar Escorts Service☎️9815674956☎️ Call Girl service in Amritsar☎️ Amri...
Sheetaleventcompany
 
Goa Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Goa No💰Advanc...
Goa Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Goa No💰Advanc...Goa Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Goa No💰Advanc...
Goa Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Goa No💰Advanc...
Sheetaleventcompany
 
Dehradun Call Girls Service {8854095900} ❤️VVIP ROCKY Call Girl in Dehradun U...
Dehradun Call Girls Service {8854095900} ❤️VVIP ROCKY Call Girl in Dehradun U...Dehradun Call Girls Service {8854095900} ❤️VVIP ROCKY Call Girl in Dehradun U...
Dehradun Call Girls Service {8854095900} ❤️VVIP ROCKY Call Girl in Dehradun U...
Sheetaleventcompany
 
Whitefield { Call Girl in Bangalore ₹7.5k Pick Up & Drop With Cash Payment 63...
Whitefield { Call Girl in Bangalore ₹7.5k Pick Up & Drop With Cash Payment 63...Whitefield { Call Girl in Bangalore ₹7.5k Pick Up & Drop With Cash Payment 63...
Whitefield { Call Girl in Bangalore ₹7.5k Pick Up & Drop With Cash Payment 63...
dishamehta3332
 

Dernier (20)

❤️Chandigarh Escorts Service☎️9814379184☎️ Call Girl service in Chandigarh☎️ ...
❤️Chandigarh Escorts Service☎️9814379184☎️ Call Girl service in Chandigarh☎️ ...❤️Chandigarh Escorts Service☎️9814379184☎️ Call Girl service in Chandigarh☎️ ...
❤️Chandigarh Escorts Service☎️9814379184☎️ Call Girl service in Chandigarh☎️ ...
 
Pune Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Pune No💰Adva...
Pune Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Pune No💰Adva...Pune Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Pune No💰Adva...
Pune Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Pune No💰Adva...
 
🚺LEELA JOSHI WhatsApp Number +91-9930245274 ✔ Unsatisfied Bhabhi Call Girls T...
🚺LEELA JOSHI WhatsApp Number +91-9930245274 ✔ Unsatisfied Bhabhi Call Girls T...🚺LEELA JOSHI WhatsApp Number +91-9930245274 ✔ Unsatisfied Bhabhi Call Girls T...
🚺LEELA JOSHI WhatsApp Number +91-9930245274 ✔ Unsatisfied Bhabhi Call Girls T...
 
Ahmedabad Call Girls Book Now 9630942363 Top Class Ahmedabad Escort Service A...
Ahmedabad Call Girls Book Now 9630942363 Top Class Ahmedabad Escort Service A...Ahmedabad Call Girls Book Now 9630942363 Top Class Ahmedabad Escort Service A...
Ahmedabad Call Girls Book Now 9630942363 Top Class Ahmedabad Escort Service A...
 
Electrocardiogram (ECG) physiological basis .pdf
Electrocardiogram (ECG) physiological basis .pdfElectrocardiogram (ECG) physiological basis .pdf
Electrocardiogram (ECG) physiological basis .pdf
 
Jual Obat Aborsi Di Dubai UAE Wa 0838-4800-7379 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi Di Dubai UAE Wa 0838-4800-7379 Obat Penggugur Kandungan CytotecJual Obat Aborsi Di Dubai UAE Wa 0838-4800-7379 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi Di Dubai UAE Wa 0838-4800-7379 Obat Penggugur Kandungan Cytotec
 
ANATOMY AND PHYSIOLOGY OF RESPIRATORY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF RESPIRATORY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF RESPIRATORY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF RESPIRATORY SYSTEM.pptx
 
👉 Chennai Sexy Aunty’s WhatsApp Number 👉📞 7427069034 👉📞 Just📲 Call Ruhi Colle...
👉 Chennai Sexy Aunty’s WhatsApp Number 👉📞 7427069034 👉📞 Just📲 Call Ruhi Colle...👉 Chennai Sexy Aunty’s WhatsApp Number 👉📞 7427069034 👉📞 Just📲 Call Ruhi Colle...
👉 Chennai Sexy Aunty’s WhatsApp Number 👉📞 7427069034 👉📞 Just📲 Call Ruhi Colle...
 
Call Girls Shahdol Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Shahdol Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Shahdol Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Shahdol Just Call 8250077686 Top Class Call Girl Service Available
 
💰Call Girl In Bangalore☎️63788-78445💰 Call Girl service in Bangalore☎️Bangalo...
💰Call Girl In Bangalore☎️63788-78445💰 Call Girl service in Bangalore☎️Bangalo...💰Call Girl In Bangalore☎️63788-78445💰 Call Girl service in Bangalore☎️Bangalo...
💰Call Girl In Bangalore☎️63788-78445💰 Call Girl service in Bangalore☎️Bangalo...
 
Dehradun Call Girl Service ❤️🍑 8854095900 👄🫦Independent Escort Service Dehradun
Dehradun Call Girl Service ❤️🍑 8854095900 👄🫦Independent Escort Service DehradunDehradun Call Girl Service ❤️🍑 8854095900 👄🫦Independent Escort Service Dehradun
Dehradun Call Girl Service ❤️🍑 8854095900 👄🫦Independent Escort Service Dehradun
 
Nagpur Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Nagpur No💰...
Nagpur Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Nagpur No💰...Nagpur Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Nagpur No💰...
Nagpur Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Nagpur No💰...
 
❤️Amritsar Escorts Service☎️9815674956☎️ Call Girl service in Amritsar☎️ Amri...
❤️Amritsar Escorts Service☎️9815674956☎️ Call Girl service in Amritsar☎️ Amri...❤️Amritsar Escorts Service☎️9815674956☎️ Call Girl service in Amritsar☎️ Amri...
❤️Amritsar Escorts Service☎️9815674956☎️ Call Girl service in Amritsar☎️ Amri...
 
Shazia Iqbal 2024 - Bioorganic Chemistry.pdf
Shazia Iqbal 2024 - Bioorganic Chemistry.pdfShazia Iqbal 2024 - Bioorganic Chemistry.pdf
Shazia Iqbal 2024 - Bioorganic Chemistry.pdf
 
Goa Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Goa No💰Advanc...
Goa Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Goa No💰Advanc...Goa Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Goa No💰Advanc...
Goa Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Goa No💰Advanc...
 
Chandigarh Call Girls Service ❤️🍑 9809698092 👄🫦Independent Escort Service Cha...
Chandigarh Call Girls Service ❤️🍑 9809698092 👄🫦Independent Escort Service Cha...Chandigarh Call Girls Service ❤️🍑 9809698092 👄🫦Independent Escort Service Cha...
Chandigarh Call Girls Service ❤️🍑 9809698092 👄🫦Independent Escort Service Cha...
 
Dehradun Call Girls Service {8854095900} ❤️VVIP ROCKY Call Girl in Dehradun U...
Dehradun Call Girls Service {8854095900} ❤️VVIP ROCKY Call Girl in Dehradun U...Dehradun Call Girls Service {8854095900} ❤️VVIP ROCKY Call Girl in Dehradun U...
Dehradun Call Girls Service {8854095900} ❤️VVIP ROCKY Call Girl in Dehradun U...
 
Most Beautiful Call Girl in Chennai 7427069034 Contact on WhatsApp
Most Beautiful Call Girl in Chennai 7427069034 Contact on WhatsAppMost Beautiful Call Girl in Chennai 7427069034 Contact on WhatsApp
Most Beautiful Call Girl in Chennai 7427069034 Contact on WhatsApp
 
Call 8250092165 Patna Call Girls ₹4.5k Cash Payment With Room Delivery
Call 8250092165 Patna Call Girls ₹4.5k Cash Payment With Room DeliveryCall 8250092165 Patna Call Girls ₹4.5k Cash Payment With Room Delivery
Call 8250092165 Patna Call Girls ₹4.5k Cash Payment With Room Delivery
 
Whitefield { Call Girl in Bangalore ₹7.5k Pick Up & Drop With Cash Payment 63...
Whitefield { Call Girl in Bangalore ₹7.5k Pick Up & Drop With Cash Payment 63...Whitefield { Call Girl in Bangalore ₹7.5k Pick Up & Drop With Cash Payment 63...
Whitefield { Call Girl in Bangalore ₹7.5k Pick Up & Drop With Cash Payment 63...
 

Diabetes and stroke

  • 1. DIABETES AND STROKE DR SUDHIR KUMAR MD (MED) DM (NEURO) CONSULTANT NEUROLOGIST APOLLO HOSPITALS, HYDERABAD
  • 2. My Talk Would Cover:  Diabetes as a risk factor for stroke,  Sugar control in patients with acute stroke,  Sugar control in post-stroke patients,
  • 3. Diabetes: Risk factor for stroke  Type 2 DM is associated with 2- to 3-fold increase in the risk of stroke.  About 10% of newly diagnosed T2DM patients develop stroke within the first 5 years of diagnosis,  The absolute risk of stroke is higher in older people (1% in 30-44 years versus 20% for >75 years old),  However, the relative risk of stroke (as compared to general population) is higher in younger people (5.6 times) (Stroke,2007)
  • 4. Factors in T2DM Predicting an Increased Stroke Risk (1)  Proteinuria (OR: 3.23)  High systolic BP (OR:3.1)  High diastolic BP (OR: 3.3)  FBS > 200 mg% (OR: 1.8)  HbA1C> 9.5% (OR: 1.7) (Stroke, 1999)
  • 5. Factors in T2DM Predicting an Increased Stroke Risk (2)  Hyperuricemia: Hazard ratio of 1.9 above mean uric acid >5 mg% (Stroke, 1998)  Age>60 (Hazard ratio 4.8 versus those <50) (Arch Int Med, 1999)
  • 6. Diabetes as a Risk Factor for Stroke in Women  Systematic review and meta-analysis of 64 cohort studies between 1966 to 2013,  Pooled maximum-adjusted RR was 2.3 in women and 1.8 in men,  Compared with men with Type 2 DM, women with Type 2 DM had a 27% greater risk of stroke. (Lancet, 2014)  Compared with men with Type 1 DM, women with Type 1 DM had a 37% greater risk of stroke. (Lancet Diabetes Endocrinol, 2015)
  • 7. Prediabetes and Risk of Stroke  Prediabetes defined as FBS 100-125 m% did not show an increase in risk of stroke,  Prediabetes defined as FBS 110-125 m% showed a modest increase in risk of stroke (RR 1.21, p=0.03),  Impaired glucose tolerance resulted in modest increase in the risk of stroke (RR 1.26, P<0.001), (BMJ, 2012)
  • 8. Hyperglycemia and Acute Stroke (1)  Among patients admitted with stroke, 40-50% have diabetes mellitus (Stroke, 2009)  Additional 20% have hyperglycemia without any history of diabetes, termed as stress hyperglycemia,  So, a total 0f 60-70% of patients with acute stroke have hyperglycemia at admission.  Admission plasma glucose>110 mg% and HbA1C> 6.2% are good predictors of (undiagnosed) diabetes mellitus in patients with acute stroke, (Age Ageing, 2004)
  • 9. Hyperglycemia and Acute Stroke (2)  Patients with hyperglycemia and acute stroke have prolonged hospital stay and incur higher hospitalization costs (Neurology 2002)  Hyperglycemia at admission in patients with stroke results in poor functional outcome at 3 months (Neurology,1999)  Hyperglycemia independently increases the risk of death at 90 days, 1 year and 6 years after stroke (all p<0.01) (Neurology 2002)
  • 10. Hyperglycemia and Acute Stroke (3)  Hyperglycemia leads to: a) Lesser salvage of mismatch tissue from infarction and b) Increase in infarct size/volume over time, thus resulting in poorer outcomes, as based on MRI diffusion-perfusion studies  Acute hyperglycemia increases brain lactate production and facilitates conversion of hypoperfused at-risk tissue into infarction. (Ann Neurology 2002)
  • 11. Sugar Control in Acute Stroke Setting  Strict sugar control would lower the sugars, thereby, improving functional outcomes; however, it may also result in hypoglycemia, resulting in brain damage.  GIST-UK trial: Patients with blood sugar between 108- 306 mg% were treated with G-K-I infusions to maintain capillary glucose between 70-125 mg%.  No difference in mortality or severe disability was seen at 90 days after stroke, as compared to placebo group. (Lancet Neurol 2007)
  • 12. Tight Sugar Control Leads to More Hypoglycemia  Glucose regulation in acute stroke patients (GRASP) trial (Stroke, 2009)  3 arms- tight control (70-110 mg%), loose control (70- 200mg%) and control usual care (70-300mg%)  Insulin infusion was used to achieve the targets,  The overall rates of hypoglycemia (<55 mg%) were 5% in loose and control usual care groups, whereas it was 30% in the tight group.
  • 13. Intensive Insulin Therapy leads to Larger Infarct growth  INSULINFARCT study (Stroke, 2012)  180 patients with MRI proven ischemic stroke (NIHSS score 5-25) were enrolled.  Received intensive insulin therapy (IIT) or usual subcutaneous insulin for 24 hours  95% within IIT group and 67% in subcutaneous insulin group had sugar within 126 mg%  Infract growth was lower in subcutaneous insulin group  Functional outcome and death rates were similar at 90 days.
  • 14. American Stroke Association Guideline  Maintain plasma glucose levels within 140 to 180 mg% in the first 24 hours,  Close monitoring should be done to detect hypoglycemia,  For patients being considered for IV thrombolysis, blood sugar should be within 50-500 mg% range. (Stroke,2013)
  • 15. Sugar Control in Post-stroke Period  Sugar control is important in patients with stroke to prevent recurrence of stroke,  Diabetes mellitus and age are two most important predictors for stroke recurrence,  About 9% of recurrent strokes are attributable to diabetes mellitus,  Diabetes is also linked to the presence of multiple infarcts on brain scan.  Goal for HbA1C level is less than 7%. (Stroke, 2006)
  • 16. CONCLUSIONS  Diabetes and prediabetes are important risk factors for stroke,  Majority of patients with acute stroke have hyperglycemia,  Hyperglycemia worsens the outcome in stroke patients,  IIT is not useful in acute stroke setting,  Moderate sugar control is advisable in acute stroke setting,  HbA1C should be less than 7% in post-stroke patients.